Registry tracking use of the CytoSorb blood-filter device in critically ill patients
Records real-world use of the CytoSorb device in critically ill people with serious conditions.
Plain-language title generated from the registry record
Registry title: CytOSorb TreatMent Of Critically Ill PatientS Registry
Key facts
- Where
- Barcelona and Huelva, SpainSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for critically ill patients who are planned to receive, or already receive, the CytoSorb 300 mL device, and who give informed consent.
- Sex
- All sexes can join.
- Disease stage
- Critically ill patients, for example with septic shock, ARDS, trauma, rhabdomyolysis, cardiogenic shock, pancreatitis, liver failure, burns or CAR-T cytokine release syndrome.
- Earlier treatment
- The CytoSorb 300 mL device must be planned or already in use.
Main reasons for not taking part
- CytoSorb 300 mL used only to remove antithrombotic drugs
- CytoSorb 300 mL used only during cardiac surgery
- A complication or medical reason after consent that makes CytoSorb 300 mL no longer appropriate
Read by machine on 9 November 2026.
Where in Spain
- Hospital Universitari Vall d'HebronBarcelona, SpainTaking people
- Hospital Juan Ramon JimenezHuelva, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- CytoSorbents, Inc
- Trial code
- NCT05146336
- Record updated
- 20 October 2026
- Original description
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient careRead full original descriptionShow less
CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Inclusion: Planned OR actual CytoSorb® 300 mL device utilization; Informed consent for prospective registry participation.
Exclusion: The occurrence of a complication or other medically justified circumstance that arises after written informed consent has been obtained from the patient and before or during the planned therapy and as a result of which the use of CytoSorb® 300 mL Adsorber is contraindicated or no longer appropriate; Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only; Use of the CytoSorb® 300 mL device for antithrombotic removal only.